Stock Events

Stock Events

Sprint Bioscience AB

€0.31

0

-€0.04-11.97% Friday 06:00

Statistics

Day High

0.31

Day Low

0.31

52W High

0.35

52W Low

0.04

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

25NovExpected

Q3 2025

999

333

-333

-999

Expected EPS

N/A

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 5JA1.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

AstraZeneca competes in the pharmaceutical and biotechnology industry focusing on the discovery and development of drugs, similar to Sprint Bioscience.

Novartis is a global healthcare company that operates in the same therapeutic areas as Sprint Bioscience, making them direct competitors in drug development.

Pfizer is involved in the development and manufacturing of health care products including innovative medicines and vaccines, overlapping with Sprint Bioscience's market.

Merck operates in the pharmaceutical industry, focusing on drug development and therapies, directly competing with Sprint Bioscience in the oncology and metabolic diseases sector.

Gilead Sciences

Gilead Sciences is a biopharmaceutical company that develops and markets drugs in areas similar to those targeted by Sprint Bioscience, including cancer treatments.

Amgen focuses on human therapeutics and operates in the same biotechnology sector as Sprint Bioscience, particularly in innovative drug development.

Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose areas of research include cancer, a key focus area for Sprint Bioscience, making them competitors.

Eli Lilly and Company develops and markets pharmaceutical products for global markets, competing with Sprint Bioscience in the areas of drug discovery and oncology.

Roche Holding AG engages in the pharmaceuticals and diagnostics business, directly competing with Sprint Bioscience in the field of oncology research and drug development.

Sanofi operates globally in pharmaceuticals, focusing on therapeutic solutions similar to Sprint Bioscience, including treatments for chronic diseases and cancer.

About

Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden. The company develops VPS34, a drug candidate for the treatment of various types of cancer by using immunotherapies; TREX1, a drug candidate for the treatment of immuno-oncology, radiotherapy and chemotherapy in the treatment of cancer. It also develops PETRA01, a drug candidate for the treatment of cancer. In addition, the company focuses on research of products for the treatment of tumor metabolism and nash. It has a research collaboration with the Experimental Drug Development Centre for expansion of metabolic dysfunction-associated steatohepatitis programme into inflammatory diseases. The company was incorporated in 2009 and is based in Huddinge, Sweden.

Show more...

CEO

Mr. Johan Emilsson

Employees

30

Country

Sweden

ISIN

SE0006343745

Listings

0 Comments

Share your thoughts

FAQ

What is Sprint Bioscience AB stock price today?▼

The current price of 5JA1.MU is €0.31 EUR — it has decreased by -11.97% in the past 24 hours. Watch Sprint Bioscience AB stock price performance more closely on the chart.

What is Sprint Bioscience AB stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Sprint Bioscience AB stocks are traded under the ticker 5JA1.MU.

Is Sprint Bioscience AB stock price growing?▼

5JA1.MU stock has risen by +9.19% compared to the previous week, the month change is a +66.58% rise, over the last year Sprint Bioscience AB has showed a +400% increase.

How many employees does Sprint Bioscience AB have?▼

As of April 18, 2026, the company has 30 employees.

In which sector is Sprint Bioscience AB located?▼

Sprint Bioscience AB operates in the Health & Wellness sector.

When did Sprint Bioscience AB complete a stock split?▼

Sprint Bioscience AB has not had any recent stock splits.

Where is Sprint Bioscience AB headquartered?▼

Sprint Bioscience AB is headquartered in Huddinge, Sweden.